
Clarence Creech
Director, Vanderbilt Vaccine Research Program · Vanderbilt University Medical Center
Credentials: · · · ·
History
- Present
Vanderbilt Vaccine Research Program · Vanderbilt University Medical Center
- Present
Center for Clinical and Translational Research · Vanderbilt University Medical Center
PresentVanderbilt Vaccine Research Program · University of California (San Diego) Medical Center


- 1995–1999
1991–1995
Research
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
New England Journal of Medicine · 2021 · 8,425 citations
Remdesivir for the Treatment of Covid-19 - Final Report
New England Journal of Medicine · 2020 · 5,321 citations
JAMA · 2022 · 529 citations

42 papers

30 papers · 6 as a fellow

16 papers

16 papers
- EA
13 papers

13 papers
- LJ
11 papers
- HS
10 papers
Grants
- 2023–2028
Interrogating Human Anti-Staphylococcal Antibody Responses for S. aureus Vaccine Insights
National Institute of Allergy and Infectious Diseases · R01
PI · $3.2M · University of California, San Diego
- 2019–2026
Vanderbilt Vaccine and Treatment Evaluation Unit
National Institute of Allergy and Infectious Diseases · UM1
Contact PI · $51.3M · Vanderbilt University Medical Center
- 2015–2023
National Institute of Allergy and Infectious Diseases · N01
Contact PI · $11.7M · University of Iowa
- 2017–2018
St. Jude/PIDS Pediatric Infectious Diseases Research Conference
National Institute of Allergy and Infectious Diseases · R13
Contact PI · $6K · Pediatric Infectious Diseases Society


